Try GOLD - Free
VFL Sciences announces cooperation with RocGene Technology
Bio Spectrum
|March 2025
Chennai-based VFL Sciences and RocGene Technology, based in China, have signed an agreement of cooperation wherein VFL Sciences will exclusively sell the entire range of products from RocGene in India.
-
This multiyear cooperation will enable both companies to explore the Indian market and devise strategies and road map to further strengthen their presence.
This story is from the March 2025 edition of Bio Spectrum.
Subscribe to Magzter GOLD to access thousands of curated premium stories, and 10,000+ magazines and newspapers.
Already a subscriber? Sign In
MORE STORIES FROM Bio Spectrum
Bio Spectrum
India & Australia develop precision nano-injection platform for breast cancer drug delivery
Researchers from the Indian Institute of Technology Madras (IIT-M), Monash University and Deakin University, Australia, have developed a cutting-edge nano-injection drug delivery platform that has the potential to make breast cancer treatment safer and more effective.
1 min
February 2026
Bio Spectrum
Agilent opens India Refurbishment Centre in Manesar
Agilent Technologies Inc., a global leader in life sciences, diagnostics, and applied chemical markets, has announced the inauguration of its India Refurbishment Centre at its LEED Platinum-certified facility in Manesar, Haryana.
1 min
February 2026
Bio Spectrum
Yashoda Medicity appoints Dr Rajinder Kumar as Unit Head, Department of Neurosurgery
Yashoda Medicity, one of the leading hospitals in the Delhi NCR, has appointed Prof. Dr Rajinder Kumar as Principal Director & Unit Head, Neurosurgery at the Yashoda Institute of Neurosciences.
1 min
February 2026
Bio Spectrum
Park Medi World buys KP Institute of Medical Sciences for Rs 245 Cr
Park Medi World Limited, North India's second largest chain of hospitals, has agreed to acquire KP Institute of Medical Sciences (KPIMS), in an all-cash transaction amounting to Rs 245 crore.
1 min
February 2026
Bio Spectrum
146 Biosimilars in 25 Years: India at Global Scale
Biosimilars are an important part of modern therapeutics and a central component of India's shift beyond a generics-led pharmaceutical model.
8 mins
February 2026
Bio Spectrum
Decode Age raises Rs 14.48 Cr to advance longevity science and gut microbiome research
Bengaluru-based Decode Age, a longevity science organisation focused on ageing biology, biomarker research and gut microbiome science, has raised Rs 14.48 crore in its Pre Series A funding round led by Dr Krishna Prasad Chigurupati, Chairman and Managing Director, Granules India Limited.
1 min
February 2026
Bio Spectrum
Havih Envirosciences announces partnership with Andhra Pradesh
Havih Envirosciences, a subsidiary of Maxwell Biosciences, has announced a strategic partnership with the Government of Andhra Pradesh to establish advanced pharmaceutical research and production capabilities in the state.
1 min
February 2026
Bio Spectrum
Biofabri and Bharat Biotech ink technology transfer agreement to advance global access to MTBVAC
Biofabri, a global human vaccine development company that is part of Spain-based Zendal group, and Bharat Biotech International Limited (BBIL) in Hyderabad, a global leader in vaccine innovation and manufacturing, have announced the signing of a Technology Transfer Agreement.
1 min
February 2026
Bio Spectrum
IIT-D and AIIMS develop swallowable microdevice for microbiome study
Researchers at the Indian Institute of Technology (IIT) Delhi, and All India Institute of Medical Sciences (AIIMS) have developed an ingestible device that can sample bacteria directly from the small intestine, opening a new window into the human gut microbiome.
1 min
February 2026
Bio Spectrum
Care ADHD expands global operations with first GCC in India
Care ADHD, one of the United Kingdom's fastest growing digital mental health companies and a key partner to the NHS, has announced the opening of its first Global Capability Centre (GCC) in India - Bengaluru.
1 min
February 2026
Listen
Translate
Change font size